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Endoplasmic reticulumCrystalline bodies (CBs) can develop in the endoplasmic reticulum (ER) of antibody-producing cells. Although this
phenotype is often reported in associationwith plasma cell dyscrasias andother hematological disorders, the details
of CB biogenesis and CB's roles in pathophysiology remain poorly understood. Using an imaging-based screening
method, we identiﬁed a secretion-competent human IgG2/λ clone that develops spindle-shaped intracellular crys-
tals in transiently-transfectedHEK293 cells uponBrefeldinA treatment.When stably overexpressed fromCHOcells,
the IgG2/λ clone spontaneously produced spindle-shaped CBs in the ER. Some CBs were released to the extracellu-
lar space while remaining enclosed by the membranes of secretory pathway origin. Structural modeling on the
variable-region did not uncover prominent surface characteristics such as charge clusters. In contrast, alterations
to the constant domain-encoded properties revealed their modulatory roles in CB-inducing propensities and CB
morphology. For example, deletion of the entire Fc domain changed the morphology of CBs into thin ﬁlaments.
Elimination of anN-linked glycan by aN297Amutation promoted Russell body biogenesis accompanied bymarked
reduction in IgG secretion. Isotype class switching from the original IgG2 to IgG1 and IgG4 changed the crystal
morphology from spindle-shaped to long needle and acicular shaped, respectively. The IgG3 version, in contrast,
suppressed the CB formation. Either the HC or LC alone or the Fc-domain alone did not trigger CB biogenesis. An
IgG's in vivo crystal morphology and crystallization propensity can thus bemodulated by the properties genetically
and biochemically encoded in the HC constant region.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Immunoglobulins can accumulate intracellularly to form protein
crystals under physiological and disease settings (recently reviewed in
[1]). Ever since the ﬁrst report on intracellular crystals by Glaus in
1917 [2], numerous clinical cases of crystalline body (CB) formation
have been documented in association with plasma cell dyscrasias in-
cluding multiple myeloma [3] and B lymphoproliferative disorders
such as lymphomas [4] and leukemias [5]. However, the details of intra-
cellular immunoglobulin crystal formation remain to be fully elucidated
despite a long history of observation. This is markedly different from
Russell bodies (RBs) [6] that have attracted wide interests from theR, complementarity-determining
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est, Seattle, WA 98119, USA.medical, scientiﬁc, and biotechnology communities during the past
120 years [7–9]. Although both CBs and RBs arise in the ER and are
composed of immunoglobulins, their phenotypic and biological rela-
tionships have not been addressed to date.
Crystallization events can be the direct consequences of biosynthetic
activities in antibody-producing cells or of catabolic processes of circulat-
ing antibodies in cells that internalize antibodies by endocytosis or
phagocytosis [4,10]. In adult Fanconi syndrome patients, for instance,
immunoglobulin crystal inclusions develop in the endosomes/lysosomes
of the proximal renal tubule cells, and the crystals are almost always
composed of the free κLCs [11,12]. In crystal-storing histiocytosis
patients, immunoglobulins crystallize in the lysosomes of macrophages
in the bone marrow, spleen, liver, lymph nodes, lung, and other organs
[13,14] and there is a clear bias toward immunoglobulins with the
κ isotype LCs [15]. In another example, a κLC expressing mouse hybrid-
oma developed CBs in the ER lumen in the absence of HC expression [16,
17]. An extreme instance of CB formation both in the ER of plasma cells
and in the lysosomes of renal tubule epithelial cells has been reported
for a single myeloma patient [3,15]. Because the lumenal pH of the
ER and the lysosomes differs, and the former organelle is for protein syn-
thesis and the latter for protein degradation, themechanisms of intracel-
lular crystal formation are expected to be different in those two
subcellular locations.
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certain intrinsic features of immunoglobulin sequence or structure and
the chemical environment of the organelle lumen, mechanisms and
requirements of CB biogenesis have been largely unknown. Attempting
to explain the immunoglobulin crystallization phenomena in the ER,
Goldberg [4] originally speculated that intracellular crystals must be
composed of structurally abnormal mutant immunoglobulins that the
cells could not secrete, and thus accumulated intracellularly. However,
identiﬁcation of a secretion-competent full-length human IgG clone
that spontaneously induced rod-shaped CBs in stably transfected CHO
cells [18] led us recently to an alternative model. We postulate instead
that intrinsic physicochemical properties embedded in the variable
region can predispose certain immunoglobulin clones to possess high
crystallization propensities. It was also shown that even when an IgG
had the predisposed propensity, intra-ER crystallization did not take
place unless a right set of conditions was met (e.g., accumulation of
export–ready IgG above a certain threshold concentration). Unlike the
stable CHO cells overexpressing the IgG clone, Brefeldin A treatment
was necessary for transiently transfected HEK293 cells to induce rod-
shaped CBs perhaps to compensate for a lower level of protein synthesis
and cargo accumulation in this cell type [18].
To gain broader insights into the process of CB biogenesis, character-
ization of a large panel of CB-inducing immunoglobulin clones is indis-
pensable. However, there is only one human IgG clone that has
been shown to reproducibly induce CB phenotypes in cell culture sys-
tems to date [18]. Using a simple imaging-based screening method, we
identiﬁed a secretion-competent, CB-inducing human IgG2/λ clone
that has different germline VH and VL origins from our previous model
human IgG2 clone (characterized in ref [18]). This newly identiﬁed IgG
clone developed spindle-shaped, or ellipsoidal, CBs in transiently
transfected HEK293 cells when IgG secretion was pharmacologically
blocked by Brefeldin A. When stably expressed in CHO cells, spindle-
shaped CBs developed spontaneously in the ER. Using this new IgG2/λ
clone, we (i) dissected the roles of Fab and Fc domains in CB biogene-
sis, (ii) delineated an unexpected phenotypic link between CBs
and the Russell bodies, and (iii) uncovered the importance of HC
isotype differences in modulating CB-inducing propensity and crystal
morphology.
2. Material and methods
2.1. Reagents and detection antibodies
All the chemicals, bioactive compounds, and reagents were obtained
from Sigma-Aldrich. Rabbit anti-calnexin was also from Sigma-Aldrich.
Mouse anti-GAPDH (clone 6C5) was from Chemicon. Mouse anti-
CD147, mouse anti-calreticulin, and mouse anti-GM130 were from BD
Transduction Laboratories. Rabbit anti-GPP130 was from Covance.
Mouse anti-ERp57 and rabbit anti-BiPwere fromAbcam.Afﬁnity puriﬁed
Rabbit polyclonal anti-human IgG (H + L) antibody was from Jackson
ImmunoResearch Laboratories. FITC- or Texas Red-conjugated and non-
labeled goat anti-humangammaandgoat anti-human lambdapolyclonal
antibodies were from Southern Biotech.
2.2. Expression constructs
Cloning methods for human IgG variable domain sequences were
previously described [9]. Brieﬂy, total RNAs were extracted from an
antibody producing hybridoma clone and reverse transcribed to obtain
cDNA sequences of the VH and VL regions. PCR was carried out using
degenerate 5′ primers that anneal to the VH or VL region and 3′ primers
to the known sequences of constant regions. Ampliﬁed variable domain
sequenceswere joined to the cognate constant domain coding sequences
via restriction site-based ligation or commonly used PCR-basedmethods
to reconstitute the entire coding regions for HC and LCwithout introduc-
ing any heterologous amino acid sequences. In an attempt to normalizethe ER targeting of nascent chains, a common signal sequence from the
Ig-HC VH5a variable gene (GenBank: AAO38734.1) was used in all the
constructs.
The constant domain sequences used in this study were identical to
the archived entries in the UniProt database under the following IDs: Ig
lambda chain, P0CG05; Ig gamma-1 chain, P01857; Ig gamma-2 chain,
P01859; Ig gamma-3 chain, P01860; and Ig gamma-4 chain, P01861.
To create an aglycosylated mutant construct, site-directed mutagenesis
PCR was performed using the gamma-2 HC construct as a template to
introduce the N297A mutation (Suppl. 1, construct 3). A truncation
construct called VH–CH1 (Suppl. 1, construct 4)was generated by ampli-
fying the region starting from the signal sequence to the end of CH1
domain followed by a stop codon using full-length gamma-2 HC con-
struct as template. The Fc-domain construct series (Suppl. 1, constructs
8–11) were generated by amplifying the region of interest starting the
residues SNTKV- (−10 position from the beginning of hinge region)
till the endogenous stop codon of individual HCs, and fused directly to
the VH5a signal sequence. The detailed domain organization for individ-
ual constructs is depicted in Supplement 1. Recombinant sequences of
interest were subcloned into pTT5 expression vector obtained from
Dr. Yves Durocher (National Research Council of Canada) to carry out
transient protein expression (see below). For the stable CHO cell line
development, a proprietary expression vector licensed from Selexis SA
was used (see below).2.3. Recombinant protein expression
2.3.1. Transient transfection and batch cell culture conditions
Expression constructs were transfected into HEK293–EBNA1 cells
(obtained from National Research Council of Canada) using the proto-
cols described elsewhere [9]. A cognate HC and LC construct pair was
co-transfected at the plasmid DNA ratio of one-to-one (normalized by
mass). When a single construct was used for transfection, 50% of the
total DNA was substituted with an empty vector to normalize recombi-
nant gene dosage. HEK293 cells were cultured in Freestyle 293 media
(Life Technologies) in suspension format using disposable cell culture
shaker ﬂasks (Corning). Cell culture ﬂasks were placed onto Innova
2100 shaker platforms (New Brunswick Scientiﬁc) rotating at 140 rpm,
in a humidiﬁed incubator (37 °C, 5% CO2). At 24 h post transfection,
cells were fed with Difco yeastolate cell culture supplement (BD Biosci-
ences). Cell culture media were collected and the whole cell lysates
were prepared on day-7 post transfection for various analytical purposes
including IgG titer determination and Western blotting. The human IgG
concentration in the harvested cell culture media was determined
with an Octet RED96 (ForteBio) using Protein A biosensors according
to manufacturer's recommendations.2.3.2. Stable CHO cell line development
The coding sequences of the LC and the HC were subcloned into
pSelexis stable expression vector licensed from Selexis SA (Geneva,
Switzerland). The expression constructs (at the HC:LC DNA ratio of
1:1, normalized by mass) were transfected into a suspension adapted
version of CHO-K1 (ATCC®CCL-61™) using Lipofectamine (Life Technol-
ogies) and cultivated in ExCell302 media (SAFC) in the presence
of 10 μg/ml puromycin. Cells were cultivated under the same growth
environment as that of HEK293 cells (above). The puromycin-
containing selection media were replaced every 2–3 days for about
2 weeks until the viability of cell population recovered to N90%. After
achieving a desired cell number and density, two hundred million cells
were collected by centrifugation (1000 g, 5 min) and re-suspended
into 100 ml of fresh nutrient-rich proprietary cell growth medium at
the starting cell density of 2 × 106 cells/ml. After 7 days of cell cultivation
in shaker ﬂasks, culturemediawere harvested by centrifugation (1000 g,
5 min). IgG titer was determined as described before.
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NuPAGE 4–12% Bis–Tris gradient gel and the accompanying running
buffer system (both from Life Technologies) were used to perform SDS-
PAGE. Harvested cell culture media and processed cell pellets were
heated for 5 min at 90 °C in lithium dodecyl sulfate sample buffer
(Life Technologies). Reducing sample preparation was performed
using the sample buffer containing 5% (v/v) beta-mercaptoethanol.
For non-reducing sample preparations, 2 mM N-ethylmaleimide was
included as an alkylating agent to prevent covalent protein adduct for-
mation. After running SDS-PAGE, resolved proteins were
electrotransferred to a nitrocellulose membrane, blocked with ﬂuores-
cent Western blocking buffer (Rockland), and probed with primary an-
tibodies. After washes in PBS containing 0.05% (v/v) Tween-20, the
nitrocellulose membranes were probed with AlexaFluor 680-
conjugated secondary antibodies (Life Technologies), followed bywash-
ing steps. The ﬂuorescent Western images were acquired by using an
Odyssey® infrared imaging system from LI-COR Biosciences.
2.5. Immunoﬂuorescent microscopy
To carry out cell imaging assays in the presence or absence of
Brefeldin A (BFA), the growth media of HEK293 suspension cell culture
were replaced with fresh media with or without 15 μg/ml BFA at 48 h
post transfection. Immediately after the media replacement, ~1 million
HEK293 cells in suspension culture were withdrawn from each shake
ﬂask and seeded onto poly-L-lysine coated glass coverslips in 6-well
plates containing a corresponding medium with or without BFA. After
24 h of static cell culture under the designated BFA conditions, cells
were ﬁxed in 0.1 M sodium phosphate, pH 7.2, containing 4% (w/v)
paraformaldehyde for 30 min at room temperature. In parallel, the
remainder of cells in the shake ﬂasks was continued to be cultivated
in suspension format for 24 h and the effect of BFA on protein secretion
was assessed by Western blotting. For CHO cells, ~750,000 cells were
withdrawn from shaker ﬂasks and seeded onto glass coverslips using
DMEM/F-12medium containing 10% FBS (both from Life Technologies),
and cultured quiescently for 24 h before the cells were ﬁxed as
described before. After washing steps in PBS containing 0.1 M glycine,
the ﬁxed cells were incubated with permeabilization buffer (PBS
containing 0.4% (w/v) saponin, 1% (w/v) BSA, 5% (w/v) ﬁsh gelatin)
for 15 min, followed by incubation with primary antibody in perme-
abilization buffer for 60min. After threewashes in permeabilization buff-
er, the cells were incubated with AlexaFluor 488- or 594-conjugated
secondary antibodies (Life Technologies) for 60 min in permeabilization
buffer. Coverslipsweremounted tomicroscope slide-glass using antifade
mounting reagent (Life Technologies). The slides were analyzed using a
Nikon Eclipse 80i or Eclipse Ti-E microscope with a 100×, 60×, or 40×
CFI Plan Apocromat oil objective lens and Chroma FITC-HYQ or Texas
Red-HYQ ﬁlter. Images were acquired using a Cool SNAP HQ2 CCD
camera (Photometrics) and Nikon Elements imaging software. For a 3D
image deconvolution, Z-stack images were captured at every 0.6 μm
section from the top to the bottom of cells in an image ﬁeld, followed
by 5 iterations of image deconvolution using the Nikon Elements 3D
restoration algorithm.
2.6. Isolation of intracellular crystals and solubilization
Intracellular crystals were isolated from transiently transfected
HEK293 cells using a previously reported method [18] with slight mod-
iﬁcations. At 72 h post transfection, cells were harvested by low speed
centrifugation (1000 g, 5 min). Intracellular crystals were released by
detergent cell lysis using PBS (pH 7.2) containing 1% Triton X-100 for
5 min on ice. Released crystals and exposed cell nuclei were collected
and thoroughly washed in excess volume of ice-cold PBS (pH 7.2) by
three repetitive centrifugation steps (1000 g, 5 min) in order to remove
residual cytosolic and detergent-extracted organelle proteins. After theﬁnal wash, released crystals were visually inspected by DIC microscopy
before they were allowed to dissolve completely in PBS (pH 7.2) by
incubating on ice for up to 3 h. During the incubation on ice, samples
were periodically monitored until the crystals were no longer detect-
able. Cell nuclear debris was subsequently removed by centrifugation
(15,000 g, 15 min). The resulting supernatant containing the dissolved
intracellular crystals were tested for sensitivity to PNGase F and
endoglycosidase H (both from New England Biolabs).3. Results
3.1. Identiﬁcation of a human IgG2/λ clone that develops spindle-shaped
crystalline bodies in the cytoplasm of HEK293 cells under ER-to-Golgi
transport block
To gain insights into the poorly understood process of CB biogenesis,
there is evident need for identifying and characterizing a new set of
well-deﬁned model IgG clones that result in CB phenotypes. In order
to fulﬁll this need, we screened a battery of recombinant full-length
human IgG clones by a transient transfection-based imaging assay.
Although CB phenotypes are considered as rare clinical manifestation
in B lymphoproliferative disorder patients [19], we identiﬁed one CB-
inducing IgG clone from our ﬁrst testing panel consisting of a dozen
unique human IgG clones. The identiﬁed clone was in the gamma-2
heavy chain (HC) subclass and in aλ light chain (LC) isotype. The closest
germline gene segments recombined to generate the VH and VL regions
of this IgG clone were VH4|4–59/DH1|1–26|RF3/JH4 and Vλ1|1e/Jλ3b,
respectively. The V-region of IgG2/λ and our previous model IgG2/κ
[18] had different germline origins.
In our standard 7-day batch cell culture method, the IgG2/λ was
robustly secreted to the culture media (Fig. 1A; Suppl. 2). The LC-only
transfection resulted in the secretion of LC covalent dimers (Fig. 1A,
left and middle, lane 2), whereas the HC-only transfection resulted in
no detectable HC secretion despite protein synthesis (Fig. 1A left, lanes
3 and 6). Brefeldin A (BFA) treatment suppressed the secretion of IgGs
effectively during the 24 h treatment period from day-2 to -3 in this
(Fig. 1A, right panel, lanes 1–2) and all the subsequent experiments
(see below) without severely compromising cell viability (data not
shown). Analysis of the cell lysates did not detect any truncated or
abnormal HC or LC species with or without BFA treatment (Fig. 1A,
right, lanes 3–4).
In the absence of BFA, recombinantly expressed IgGs localized to
tubular and reticular structures in the cytoplasm of transfected cells
(Fig. 1B, top row) and developed CB phenotypes only rarely [0.8%;
Suppl. 3, row 4]. In the presence of BFA, roughly 30% of the transfected
cells developed spindle-shaped or ellipsoidal CBs intracellularly
(Fig. 1B, second and third rows; Suppl. 3, row 3). The size of individual
CBs as well as the number of CBs per cell varied from cell to cell (1B,
bottom row).When individual subunit chainswere expressed indepen-
dently, no CB phenotype was induced (Suppl. 3). However, 44.87% of
the HC-only transfected cells developed Russell body (RB) phenotypes
at steady state, accompanied by cell rounding (Fig. 1C, second row;
Suppl. 3). None of the LC-only transfected cells developed RB pheno-
types (Fig. 1C, top row; Suppl. 3). RBs are globular inclusion bodies com-
posed of aggregated immunoglobulins or the subunits. RBs can entrap
ER-resident proteins when they are induced by full-length human
IgGs [9]. When RBs were caused by a deletion mutant of μ-HC lacking
the CH1 domain (ΔCH1–μHC), ER resident proteins were reportedly
excluded from the RBs [7]. Although RBs are typically formed in the
ER, they can also develop in ERGIC [20]. When co-stained with ER
resident proteins, the HC-derived RBs were also positive for BiP/Grp78
(Fig. 1C, bottom row, arrowheads) and other ER markers such as
calreticulin, calnexin, or ERp57 (data not shown), suggesting that the
presence of intact CH1 domain facilitates the co-condensation of ER
resident proteins into the RBs.
1328 H. Hasegawa et al. / Biochimica et Biophysica Acta 1843 (2014) 1325–1338
Fig. 2. Spindle-shaped crystalline bodies are induced spontaneously when stably overexpressed in CHO cells. Suspension cultured CHO cells stably expressing the human IgG2/λ clone
were plated onto glass coverslips and statically cultured for 24 h before the cells were ﬁxed and imaged using a DIC microscope. Depending on the number of crystals per cell, crystal
morphology, or the apparent location of crystalline body (CB), the cellular phenotypes were classiﬁed into six categories: (a) single CB per cell, (b) a few CBs per cell, (c) numerous
CBs per cell, (d) crisscross shaped CBs, (e) dendritic shape CB, and (f) extracellular localization.
1329H. Hasegawa et al. / Biochimica et Biophysica Acta 1843 (2014) 1325–1338CBs were induced in transfected cells that co-express the HC–LC
subunit pair. The fact that not all the transfected cells could equally
induce CB phenotypes suggests that the cell-to-cell variation in theFig. 1. A newly-identiﬁed human IgG2/λ clone induces spindle-shaped crystalline bodies in
and whole cell lysates were processed at day-7 post transfection and were subjected to SDS
human IgG (H + L) polyclonal antibody. Heavy chain (HC) and light chain (LC) are pointed by
lanes. Anti-GAPDH blot is shown for the cell lysate lanes 4–6 as a loading reference. In this and a
mediumwas analyzed in each lane. For the cell lysate lanes, whole cell lysate equivalent to 12,0
day-7 were analyzed under non-reducing conditions and probed by anti-human IgG (H+ L) po
mers were also co-secreted and detectable in the same lane. (A, right panel) Cell culture med
Brefeldin A (BFA) treatment were analyzed by Western blotting using anti-human IgG (H + L
and LC of the IgG2/λ clone. On day-2 post transfection, cells were seeded onto glass coverslip
of 15 μg/ml BFA. On day-3, the cells were ﬁxed and immuno-stained. Co-staining was carried o
overlaid to create amerged view. (C) HEK293 cells were transfected by the LC construct alone (t
anti-CD147 and anti-lambda (top) or anti-CD147 and anti-gamma (second row). HC-expressinIgG cargo concentration in the ER plays some role as to which cells
develop the CB phenotype. In transiently transfected HEK293 cells,
this concentration appears to be rarely achieved spontaneously and atransfected HEK293 cells under Brefeldin A treatment. (A, left panel) Cell culture media
-PAGE under reducing conditions, followed by a Western blotting analysis using anti-
arrowheads. Constructs used to transfect the cells are shown at the top of corresponding
ll the subsequent analysis, a sample volume corresponding to 5 μl of harvested cell culture
00–13,000 cells was loaded in each lane. (A, middle panel) Cell culture media harvested at
lyclonal antibody. Determined IgG titer is shown next to lane 1. Free LC dimers andmono-
ia (lanes 1–2) and cell lysates (lanes 3–4) prepared at day-3 post transfection after 24 h
) polyclonal antibody. (B) Fluorescent micrographs of HEK293 cells co-expressing the HC
s and cultured quiescently for 24 h in the absence (ﬁrst row) or the presence (rows 2–4)
ut by using anti-gamma (green) and anti-lambda (red). Green and red image ﬁelds were
op row) or theHC construct alone (second and third rows). The cells were co-stainedwith
g cells were stained with anti-gamma and anti-BiP/Grp78 (bottom row).
1330 H. Hasegawa et al. / Biochimica et Biophysica Acta 1843 (2014) 1325–1338forced cargo accumulation by BFA treatment was necessary to reach
such concentration in selected cells.
3.2. Stably transfected CHO cells spontaneously develop spindle-shaped
crystalline bodies in the ER
Because BFA can broadly alter organellemorphology andmembrane
trafﬁcking dynamics of endomembrane systems [21], BFA-treated cells
are not suitable for morphological study to determine the subcellular
localizations of CBs. With a goal to achieve high level protein synthesis
so as to induce CB formation spontaneously, we established a stably-
transfected CHO cell pool. In a 7-day batch cell culture condition used,
the secretion level was 368.3 ± 56.7 mg/L (n = 3) and the apparent
cell speciﬁc productivity (Qp) was 6.7 ± 0.4 μg/106 cells/day (n = 3)
(~2.5 × 106 IgGs/cell/day). At steady state, about 20% of the cells in
this stable CHO cell pool spontaneously developed CB phenotypes
which we arbitrarily classiﬁed into six categories (Fig. 2). The vast
majority of CB-positive cells housed one or up to several CBs per cell
(rows a–b), while some cells harbored numerous spindle-shapedFig. 3. Spindle-shaped crystalline bodies are enclosed in the membranes of early secretory p
statically cultured for 24 h before the cells were ﬁxed and immuno-stained. (A) Staining wa
rows); anti-human IgG (H+ L) and anti-GM130 (third and fourth rows). (B) Extracellularly de
deposited CBswere stained by anti-calnexin and anti-GM130. The boxed area in the top row is e
the cells in order to capture extacellular CB in focus. At this focal plane, it was often difﬁcult tocrystals per cell (row c). The spindle-shaped CBs fused into crisscross
and dendritic morphology (rows d–e) in some cells. Extracellular CBs
were also detected as well (row f). Co-staining with various markers
of subcellular organelles suggested that CBs were fully enclosed by
calnexin positive membranes while occasionally juxtaposed to cis-
Golgi markers such as GM130 (Fig. 3A). In contrast, markers of nuclei,
mitochondria, endosomes, and lysosomes showed no apparent co-
localization or association with CBs (data not shown). Because of the
crystalline nature of CBs, polyclonal anti-human IgG could only stain
the surface of CB and the staining was excluded from the body of CB it-
self, suggesting that the detection antibodies could not penetrate into
the CBs to stain the entire crystalline structure. Unlike the cases of
RBs, ER resident proteins were excluded from the crystalline structure.
Co-staining with organelle markers showed that extracellular CBs
were still enclosed by membranes of secretory pathway organelles of
mostly ER origin as suggested by the calnexin staining with some
punctated areas of GM130 (Fig. 3B). This suggested that the release of
pre-existing intracellular CBs to the extracellular space is much more
likely than the de novo formation of CBs in the extracellular space.athway organelle. Suspension cultured CHO cells were seeded onto glass coverslips and
s performed using the following antibody sets: anti-calnexin and anti-GM130 (ﬁrst two
posited crystals were still surrounded by amembrane of ER origin. Cells and extracellularly
nlarged in the bottom row. The focal plane of the imagewas adjusted close to the bottomof
see clear-cut calnexin staining.
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surface characteristics
In our previous model human IgG2/κ clone [18], computational
structural modeling on the variable fragment revealed a prominent
acidic cluster which turned out to be essential for the crystallization
events at neutral pH environment both in vivo and in vitro. EnvisioningFig. 4.N297A aglycosylationmutant promotes Russell body formation instead of crystalline bod
SDS-PAGE under reducing conditions (lanes 1–5) or non-reducing conditions (lanes 6–10).Wes
molecule ismarked by (*) in lane 10. (B) Cell culturemedia (left panel) and cell lysates (right pa
by Western blotting using anti-human IgG (H + L) polyclonal antibody. (C) Fluorescent micr
mutant (second–third rows) at steady state without BFA treatment. Co-staining: anti-gamma
IgG2/λ clone (top row) or the aglycosylated N297A mutant (bottom row) statically cultured 2
the aglycosylated mutant developed Russell bodies. Co-staining: anti-gamma (green), anti-lama similar scenario, we initially hypothesized that the newly-identiﬁed
human IgG clone may also possess readily identiﬁable characteristics
on the variable domain surface. However, structural modeling did not
reveal any notable surface features that can be rationally targeted by
mutagenesis. Instead, positive, negative, and non-charged polar resi-
dues were distributed almost evenly on the surface of the V-region
without creating a localized charge patch (data not shown). The lackies. (A) Cell culturemediawere harvested at day-7 post transfection andwere subjected to
tern blottingwas performedusing anti-human IgG (H+ L) polyclonal antibody. IgG4 half-
nel)were processed at day-3 post transfection after 24 h BFA treatment andwere analyzed
ographs of HEK293 cells expressing IgG2/λ clone (top row) or the aglycosylated N297A
(green), anti-lambda (red). RBs are pointed by arrowheads. (D) HEK293 cells expressing
4 h in the presence of BFA. The parental IgG2/λ clone developed crystalline bodies, while
bda (red).
Fig. 5. Fab domain is sufﬁcient to induce ﬁlamentous crystalline bodies. (A) Cell culture media were harvested at day-7 post transfection and were subjected to SDS-PAGE under reducing
(lanes 1–3) or non-reducing (lanes 4–6) conditions. Protein identity is marked on the gel based on the results of Western blotting or mass spectrometry. The protein of ~73 kDa (marked
by *) is an unidentiﬁed host-derived protein. (B) Cell culture media harvested on day-7 were subjected to SDS-PAGE under non-reducing conditions and analyzed by Western blotting
either by anti-lambda antibody (left panel) or anti-gamma antibody (right panel). The Fab protein is detectable by both anti-lambda and anti-gamma antibodies when the proteins
were resolved under non-reducing conditions. (C) Cell culture media collected at day-3 post transfection after 24 h BFA treatment were analyzed by Western blotting under non-
reducing conditions using anti-lambda (left) or anti-gamma (right). (D) Fluorescent micrographs of HEK293 cells expressing the Fab construct at steady state without BFA treatment.
The VH–CH1 construct was stained by anti-gamma (green). The LC was stained by anti-lambda (red). (E) Fluorescent micrographs of HEK293 cells expressing the Fab constructs after
24 h static culture in the presence of BFA. (F) Fluorescent micrographs of HEK293 cells expressing the VH–CH1 construct alone at steady state without BFA treatment (top row) or after
24 h BFA treatment (bottom row).
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strategy to investigate the roles of constant regions, particularly those
of the HC subunit.
3.4. N297A aglycosylation mutation promotes Russell body formation
instead of crystalline bodies
Theﬁrst approachwe employedwas to alter theHC constant domain
properties by mutating the conserved N-linked glycosylation site located
at the position 297 in the CH2 domain (Suppl. 1, construct 3). This
N-glycan is known to play important functions during the protein fold-
ing events in the ER [22] and stabilization of folded IgG conformation
[23]. Firstly, we found that the N297A aglycosylation mutation resulted
in marked reduction in secretion titer (~70% decrease on average, n =
3) compared to its glycosylated counterpart under identical transfection
and cell culture conditions (Suppl. 2; Fig. 4A, lanes 2–3 and 7–8). An
expected gel mobility shift was observed for the mutant HC because
of themissing N-linked glycan (Fig. 4A, lanes 2–3). Secondly, the aglyco
mutant showed a much higher propensity to induce RBs compared to
its glycosylated counterpart at steady state (7.0% vs 44.7%; Fig. 4C,
arrowheads; Suppl. 3). RB phenotypes were typically accompanied by
cell rounding as shown previously in HEK293 cells [9]. Various ER resi-
dent proteins co-localized with (or entrapped in) the RBs at steady
state (data not shown, also see below). Under BFA treatment (Fig. 4B,
lanes 3–6), the aglycomutant increased the prevalence of RB phenotype
to 71.9%without inducing any detectable CBphenotype (Fig. 4D, bottom;
Suppl. 3). The presence or absence of N-linked glycans determined
whether an IgG clone develops the CB or RB phenotype, like a switch.
3.5. Fab domain of the IgG2/λ clone induces ﬁlamentous inclusion bodies
The second approach was to examine whether Fc-domain encoded
information is necessary for CB biogenesis. To test CB formation in the
absence of Fc, we produced a recombinant Fab protein by removing
the Fc portion from the HC to generate a VH–CH1 domain construct
(Suppl. 1, construct 4) and co-expressed it with the LC. When the
cell culture media were analyzed on day-7, Coomassie blue staining
revealed two major proteins corresponding to ~25 kDa and ~27 kDa
under reducing conditions (Fig. 5A, lane 1). Western blotting using a
polyclonal anti-lambda antibody indicated that the upper band was the
LC. We veriﬁed the identity of the lower protein band by LC-MS/MS
(data not shown) because our polyclonal anti-gamma antibody could
not detect VH–CH1 protein in Western blotting under reducing condi-
tions. Under non-reducing conditions, the LC and the VH–CH1 domain
construct remained covalently associated and appeared as a ~49 kDa
protein (Fig. 5A, lane 4) which was detectable by both anti-gamma and
anti-lambda antibodies in Western blotting (Fig. 5B, lanes 1 and 4).
Co-transfection of the VH–CH1 and LC construct pair resulted in the
formation of ﬁlament-like cytoplasmic inclusions in 5.1% of transfected
cells at steady state (Fig. 5D; Suppl. 3). Unlike the spindle-shaped CBs
generated by the full-length IgG2/λ, the Fab-derived cytoplasmic
ﬁlaments were difﬁcult to discern by DIC microscopy. Nonetheless,
these ﬁlaments were stained directly by both anti-gamma and anti-
lambda antibodies (Fig. 5D) suggesting that the detection epitopes were
accessible. Under an ER-to-Golgi transport block condition (Fig. 5C,
lanes 1–2, 7–8), the co-transfected cells induced similar ﬁlamentous
inclusion bodies at a frequency of 6.8% (Fig. 5E, top row; Suppl. 3). In
many instances, the cells developed long thin needle CBs that protruded
far beyond the cell diameter, reaching up to 80 μm in length (Fig. 5E).
We attempted to determine the subcellular localizations of the
ﬁlamentous inclusion bodies at steady state by co-staining with selected
organelle markers. Because ﬁlamentous CBs did not entrap resident pro-
teins as part of the structure, unequivocal co-localizationwith known ER
andGolgimarkerswas technically difﬁcult (Suppl. 4). Given the dramatic
CB elongation upon BFA treatment, however, it wasmost likely that they
localized in the ER. When expressed alone, the VH–CH1 protein wasarrested in the ER and aggregated into RBs in nearly all the cells express-
ing the construct, irrespective of the BFA treatment (Fig. 5F) [92.7%
without BFA, 94.4% with BFA; Suppl. 3]. ER resident proteins such as
BiP, calreticulin, and ERp57 were concentrated in the RBs made of
VH–CH1 construct (Suppl. 5).
3.6. IgG HC subclass differences modulate CB induction and CB morphology
Anotherway to test the roles of HC constant domain in CB biogenesis
is to examine the effect of different HC isotypes. Depending on how the
V-region specifying gene segments are joined to the constant domain-
encoding gene segments, four different IgG HC subclasses (namely, G1,
G2, G3, and G4) can be generated for a given VH domain. To test this,
we recombinantly class switched from the original IgG2 to the IgG1,
IgG3, and IgG4 subclasses (Suppl. 1, constructs 5–7). Secretion titers for
the newly-generated IgG subclasses were largely comparable to the
parental IgG2 (Fig. 4A, lanes 1, 4, 5; Suppl. 2). It is important to note
that IgG4 expectedly generated half-IgG molecules of ~75 kDa (Fig. 4A,
lane 10, marked by *) in addition to the whole IgGs [24].
When the phenotype of IgG expressing cellswas examined,we found
that ‘V-region identical antibodies’ in four different gamma-chain sub-
classes resulted in varyingCB-inducing propensities and distinct CBmor-
phology. The IgG1 version produced needle-shaped CBs at steady state
(5.4%) that elongated up to 100 μm upon 24-h BFA treatment, along
with an increase in CB frequency (16.7%) (Fig. 6A; Fig. 4B, lanes 1–2;
Suppl. 3). These needles occasionally stabbed bystander cells, whereby
inﬂuencing the health and the fate of other cells in the vicinity. The
IgG3 version, in contrast, did not induce detectable CBs (Fig. 6B; Fig. 4B,
lanes 7–8; Suppl. 3). IgG3's extended hinge region may have increased
the ﬂexibility and heterogeneity of the molecule [25] and disfavored
crystallization. The IgG4 version, on the other hand, produced acicular
(or slender spindle) CBs at the highest frequency among all the IgG
subclasses examined in this study, both at steady state (19.0%) and
under BFA treatment (47.2%) (Fig. 6C; Fig. 4B, lanes 9–10; Suppl. 3).
3.7. Intracellular crystals are composed of endoglycosidase H-sensitive
human IgGs
In order to test whether the apparent ER localization of CBs is
biochemically substantiated, we analyzed the N-linked glycan proper-
ties of the IgGs isolated from intracellular crystals (see Section 2.6).
Based on the high spontaneous CB phenotype frequency, we employed
IgG4-expressing HEK293 cells (Section 3.6) as the source of intracellular
crystals. Similar to the stable CHO cells expressing IgG2-version, IgG4
crystals in HEK293 cells were fully enclosed by calnexin positive mem-
branes (Fig. 7A, top)while located in the vicinity of GM130-positive cis-
Golgi membranes (Fig. 7A, bottom). Fully solubilized IgG4 samples
prepared from intracellular crystals contained not only correctly assem-
bled whole IgGs, but also half-IgGs and LC dimers (Fig. 7C). When the
secreted IgG4 in the culture media and crystal-derived IgG4 were sub-
jected PNGase F digestion, the gel mobility of the HC subunit shifted ex-
pectedly both in secreted and crystal-derived IgG4s (Fig. 7D, lanes 1 & 3).
In contrast, while the intracellular crystal-derived IgG4 remained
sensitive to endoglycosidase H treatment (Fig. 7D, lane 5), the IgG4s
secreted to the culture media were resistant to the same treatment
(Fig. 7D, lane 7). Intracellular CBs were hence composed of IgG species
that had not been transported out of the ER to reach medial-Golgi
compartment where N-glycans acquire endo H-resistance.
3.8. Crystalline bodies do not form in the absence of LC expression
In the Sections 3.1 and 3.5, G2 subclass HC and VH–CH1 fragments
were already shown to induce RBs without resulting in CB phenotypes
in the absence of LC co-expression. Similar to those two cases, regard-
less of the HC subclass used, the HC-only expression simply induced
RB phenotypes in ~36% to ~64% of transfected cells without inducing
Fig. 6. IgG HC subclass difference modulates crystalline body induction and morphology. Fluorescent micrographs of HEK293 cells expressing (A) IgG1, (B) IgG3, and (C) IgG4 versions of
theparental IgG2 clone at steady statewithout BFA treatment (top row)or after 24h BFA treatment (bottom row).DIC image, anti-gamma staining (green), and anti-lambda staining (red)
are merged into one image view. Five independent microscopic ﬁelds are shown for each condition, with or without BFA.
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Likewise, the HC only secretion was not detectable for the G1, G3, and
G4 gamma-chain subclasses despite protein synthesis (data not
shown). These results lent support for the necessity of the LC–HC pair
co-expression to acquire crystallogenic propensity and secretion
competence.3.9. Fc domain overexpression does not induce crystalline body formation
Although the Fab domain was sufﬁcient to induce thin needle-like
ﬁlamentous CBs (Section 3.5), we examined whether the Fc domain
alone can independently induce CBs without the Fab portion. To facili-
tate the ER targeting and the secretion of Fc domain constructs to the
culture media, we fused a signal sequence derived from the VH5avariable subgroup gene to the hinge-CH2–CH3 regions of four
gamma-chain subclasses (Suppl. 1, constructs 8–11).
Secretion level was high and comparable for all four Fc domain
constructs (Suppl. 2; Fig. 9 A–B, lanes 1–4). G1–Fc, G2–Fc, and G3–Fc
did not induce CBs or RBs regardless of the BFA treatment, but frequent-
ly developed cytoplasmic aggregates that were not stained by anti-
gamma chain or by anti-calnexin antibody (Fig. 9C, arrowheads). The
identity of those cytoplasmic structures was not examined fully in this
study, but by appearance, they resembled aggresomes that develop in
the cytosol. G4–Fc induced moderate levels of RBs at steady state
(15.4%), and such propensity increased under BFA treatment (34.8%),
with no detection of CBs (Fig. 9D; Suppl. 3).
The Fc (‘fragment crystallizable’) was so named because of its
crystallizable propensity in vitro at high concentrations in cold temper-
atures [26]. However, the recombinantly expressed Fc domains by
Fig. 7. Intracellular crystals are composed of IgG species with endoglycosidase H sensitive N-glycan. (A) IgG4 overexpressing HEK293 cells developed intracellular crystals spontaneously.
Transfected cells were stained by anti-calnexin (top) or anti-GM130 (bottom). (B) Intracellular crystals were released by detergent cell lysis. The presence of crystals was inspected by DIC
microscopy after the crystals were thoroughly washed in PBS. Nuclear debris are marked by (*). Scale bar = 10 μm. (C) Fully dissolved IgG4 intracellular crystals were analyzed by Western
blotting side-by-side with IgG4 secreted to the culture media. Left panel, reducing. Right panel, non-reducing. (D) Secreted and intracellular crystal IgG4 were treated with PNGase F (lanes
1–4) or endoglycosidase H (EndoH; lanes 5–8). Enzyme-treated IgG4was resolved by SDS-PAGE to examine the gelmobility under reducing conditions. HC and LC are pointed by arrowheads.
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environment of the ER lumen.4. Discussion
4.1. Roles of variable domain properties in crystalline body formation
Prior to this study, two independent immunoglobulin clones have
been reported to induce CBs in reproducible cell culture models. The
ﬁrst example was a mouse IgG3/κ clone [27]. This mouse clone induced
rod-shaped CBs inside the hybridoma cells under normal culture condi-
tions. Rengers et al. [27] showed that a spontaneously generated vari-
ant, which differed only by three amino acids (i.e., deletion of -S-V-E-
in the κLC CDR1), did not have such intracellular crystallization propen-
sity. In the second example, Hasegawa et al. [18] reported a human
IgG2/κ clone that induced rod-shaped CBs spontaneously in the ER of
a recombinant CHO cell line. Structural modeling revealed the presence
of a prominent acidic charge cluster composed of ﬁve aspartic acid res-
idues on the VH CDRs. Mutagenesis of these ﬁve aspartate residues into
alanine or serine abrogated the crystallization propensities both in vivo
and in vitro. For the newly-identiﬁed human IgG2/λ clone, however, we
could not identify notable features within the variable domain that
could have guided us to take a mutagenesis approach to substantiate
the importance of V-region in crystallization events. We were able toshow that the Fab portion alonewas sufﬁcient to induce CB phenotypes
and unpaired individual subunits were not able to generate crystals;
however, we were unable at this time to pin down speciﬁc and identiﬁ-
able attributes within the V-region that had contributed to the CB
biogenesis. Detailed understanding of the molecular packing in the in-
vivo generated crystals will be necessary to address any cryptic attributes
hidden in the V-region.4.2. Roles of HC constant domain properties in CB phenotype diversity
The current studyprovides a biochemical basis for the diversiﬁcation
of CB morphology. Different shapes of crystalline inclusion bodies were
induced from a single IgG clone depending on the HC isotype class
differences and presence of the Fc-portion. While the HC or the Fc-
domain by itself was not sufﬁcient to induce CB formation, the differ-
ences encoded in the constant domain regions could suppress CB forma-
tion, modulate CB-inducing propensity, or change crystal morphology.
Although our focus in this study was the four different subclasses of
IgG isotype, it is of interest to ﬁnd out the differences in CBmorphology
among ‘V-region identical antibodies’ in IgM, IgD, IgA, or IgE format.
What difference does itmakewhen cells house different shapes of CBs
inside of them? In our previous study [18], a human IgG2/κ clone devel-
oped long rod-shaped CBs and frequently resulted in marked cell
enlargement accompanied by multi-nucleation. Such cell enlargement
Fig. 8. TheHC subunits are prone to aggregate into Russell bodies in the absence of LC expression. (A) Fluorescentmicrographs of HEK293 cells expressing the HC (G1) construct. On day-2
post transfection, cellswere seeded onto glass coverslips and culturedquiescently for 24h in the absence (top row) or thepresence (bottom row) of BFA.Onday-3, the cellswere ﬁxed and
immuno-stained with anti-CD147 (green) and anti-gamma (red). Similar staining experiments were carried out for the HC (G2-aglyco) construct (B), the HC (G3) construct (C), and the
HC (G4) construct (D). In all cases, transfected cells showed Russell body phenotypes.
1336 H. Hasegawa et al. / Biochimica et Biophysica Acta 1843 (2014) 1325–1338phenotype for CB-laden cellswas reported as early as 1949 [10], butwith-
out having been mechanistically accounted for. In one case, intracellular
crystals often outgrew the cell's diameter and continued until the elon-
gating crystals eventually punctured the cells [18]. It was proposed that
the intracellular rod-shaped crystals physically impeded cell divisionwithout preventing cell volume growth and nuclear division. In contrast,
the human IgG2/λ clone characterized in this study developed short
grain-like CBs that did not appear to interfere with the cytokinesis of
recombinant CHO cells. Cell enlargement and multi-nucleation pheno-
type rarely occurred, but nonetheless crystals were opportunistically
Fig. 9. Fc domain constructs do not induce crystalline bodies. (A) Cell culturemedia were harvested at day-7 post transfection andwere subjected to SDS-PAGE under reducing conditions
(lanes 1–4) or non-reducing conditions (lanes 9–12). Cell lysates were analyzed under reducing conditions (lanes 5–8). Western blotting was performed using anti-human IgG (H+ L)
polyclonal antibody. The half-molecule for G4–Fc ismarked by (*) in lane 12. Determined Fc domain protein titers are shown in the corresponding lanes 1–4. Due to a technical difﬁculty of
measuring G3–Fc by protein A-basedmethod, theG3–Fc titerwas not determined (N/D) in lane 3. TheG2–Fcwas secreted as disulﬁde-linked heterogeneous covalent oligomers (lane 10).
(B) Coomassie blue stainingof the day-7 cell culturemedia, under reducing conditions (lanes 1–4) andnon-reducing conditions (lanes 5–8). TheG4–Fchalf-molecules aremarkedby (*) in
lane 8. (C) Fluorescentmicrographs of HEK293 cells expressingG1–Fc (top row), G2–Fc (second row), and G3–Fc (rows 3–4) constructs are shown. Cellswere seeded onto glass coverslips
on day-2 post transfection and cultured statically for 24 h in the absence of BFA treatment. On day-3, cells were ﬁxed and immuno-stained with anti-gamma (green) and anti-calnexin
(red). Unidentiﬁed cytoplasmic inclusion bodies resembling aggresomes are pointed by arrowheads. The aggresome-like inclusions were not stained by anti-gamma or anti-calnexin,
and appeared to localize in the cytosol, rather than in the ER. (D) Fluorescent micrographs of HEK293 cells expressing the G4–Fc construct. Cells were ﬁxed after 24 h in the absence
(top row) or the presence (bottom row) of BFA. On day-3, cells were ﬁxed and immuno-stained with anti-gamma (green) and anti-calnexin (red) (top row) or anti-CD147 (green)
and anti-gamma (red) (bottom row). Aggresome-like inclusion bodies showing negative staining for Fc and calnexin are pointed by arrowheads in the top row. Some selected RBs are
pointed by arrows.
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crystals and how fast they grow inside the cells, the intracellular crystals
can become cytotoxic by breaching the membrane integrity (but appar-
ently not by apoptosis). Whether this type of delayed onset cytotoxicity
by physical membrane breaching can play signiﬁcant roles in pathophys-
iology is unknown.
4.3. Phenotypic relationships between crystalline body and Russell body
Both CBs andRBs are composed of immunoglobulins and both devel-
op during biosynthetic steps. However, phenotypic and biological rela-
tionships between the two types of inclusion bodies have never been
addressed. In mice homozygous for viable motheaten (mev) allele, CB-
containing plasma cells and RB-housing cells were found side by side
in the same lymph nodes [28], but it was attributed to the polyclonal na-
ture of B cell activation in this autoimmune mouse. The present study
unexpectedly revealed that a single monoclonal immunoglobulin can
give rise to both kinds of cellular phenotypes depending on the presence
or absence of the N-linked glycan in the CH2 domain. Cellular defects in
N-linked glycosylationmachinery or other steps that inﬂuence this post-
translational modiﬁcation [29] could potentially play roles in CB to
RB phenotype conversion in disease settings or aberrant cell culture
conditions. While the possibility of CB to RB conversion was shown in
this study by a deﬁned genetic/biochemical manipulation, whether RB
phenotypes can be converted to CB phenotypes is not known.
From a biological point of view, developing CB or RB phenotypes has
different implications on the fate of immunoglobulin-expressing cells
and also to the host. As a result of misfolded protein aggregation in
the ER, RB formation can exacerbate cell health and cause cytotoxicity
to the immunoglobulin-expressing cell hosts [9]. Such cellular popula-
tions can be eliminated by degeneration. This seems to be the basis for
why the RB phenotype is proposed as a model for ER storage diseases
[20,30]. In contrast to RBs, all three molecularly characterized CB-
inducing IgG clones were robustly secreted in spite of the intracellular
crystal formation [18,27]. Depending on whether a given IgG clone has
RB- or CB-inducing propensities, extracellular concentration of secreted
IgGs in circulation can be widely different. Furthermore, unlike those of
RBs, the immunoglobulin species comprising the CBs were not only
correctly folded and assembled but also reversibly soluble and retained
antigen binding [18]. It is therefore likely that (unlike those of RBs)
chaperone insufﬁciency is not playing a key role in the development of
CB phenotypes.
The mechanistic understanding of CB biogenesis has not progressed
until recently partly due to the lack of suitable and reproducible recom-
binant cellular model systems. We expect that the simple phenotype
screeningmethod using HEK293 transient expression systemswill pro-
vide a tool to unearth new sets of immunoglobulin clones that can
induce CB phenotypes. Characterization on each immunoglobulin clone
should, in return, expand our understanding on the mechanisms of CB
biogenesis and the biophysical basis of liquid–solid phase separation
events that takes place in the secretory pathway organelles.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.03.024.
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